In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation

Antiviral Research

Volumn 75, Issue 2, 2007, Pages 139-145

  Wang, Yan ^a   Wei, Lai ^a   Jiang, Dong ^a   Cong, Xu ^a   Fei, Ran ^a   Chen, Hongsong ^a   Xiao, Jiang ^a   Wang, Yu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Basic core promoter; Hepatitis B virus; Interferon alpha; Mutation

Indexed keywords

CALCIUM PHOSPHATE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE MUTATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION; VIRUS RESISTANCE;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, VIRAL; GENOME, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERFERON-ALPHA; MUTAGENESIS, SITE-DIRECTED; PLASMIDS; POINT MUTATION; PROMOTER REGIONS (GENETICS); TRANSFECTION; VIRAL CORE PROTEINS; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 34247618221     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.02.001     Document Type: Article

References (28)

1. Baumert T.F., Marrone A., Vergalla J., and Liang T.J. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J. Virol. 72 (1998) 6785-6795
2. Berger J., Hauber J., Hauber R., Geiger R., and Cullen B.R. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66 (1988) 1-10
3. Buckwold V.E., Xu Z., Chen M., Yen T.S., and Ou J.H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J. Virol. 70 (1996) 5845-5851
4. Buckwold V.E., Xu Z., Yen T.S.B., and Ou J.-H. Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J. Gen. Virol. 78 (1997) 2055-2065
5. Caselmann W.H., Meyer M., Scholz S., Hofschneider P.H., and Koshy R. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J. Infect. Dis. 166 (1992) 966-971
6. Chun Y.K., Kim J.Y., Woo H.J., Oh S.M., Kang I., Ha J., and Kim S.S. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection. Hepatology 32 (2000) 1154-1162
7. Cullen B.R., and Malim M.H. Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol. 216 (1992) 362-368
8. Diepolder H.M., Ries G., Jung M.C., Schlicht H.J., Gerlach J.T., Graner N., Caselmann W.H., and Pape G.R. Differential antigen-processing pathways of the hepatitis B virus e and core proteins. Gastroenterology 116 (1999) 650-657
9. Erhardt A., Reineke U., Blondin D., Gerlich W.H., Adams O., Heintges T., Niederau C., and Haussinger D. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B. Hepatology 31 (2000) 716-725
10. Guidotti L.G., Matzke B., Pasquinelli C., Shoenberger J.M., Rogler C.E., and Chisari F.V. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J. Virol. 70 (1996) 7056-7061
11. Gunther S., Li B.C., Miska S., Kruger D.H., Meisel H., and Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol. 69 (1995) 5437-5444
12. Gunther S., Piwon N., and Will H. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) → T, A(1762) → T and G(1764) → A mutations in the core promoter. J. Gen. Virol. 79 (1998) 375-380
13. Hadziyannis S.J., Tassopoulos N.C., Heathcote E.J., Chang T.T., Kitis G., Rizzetto M., Marcellin P., Lim S.G., Goodman Z., Wulfsohn M.S., Xiong S., Fry J., Brosgart C.L., and Adefovir Dipivoxil 438 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N. Engl. J. Med. 348 (2003) 800-807
14. Hamasaki K., Nakata K., Nakao K., Misuoka S., Tsutsumi T., Kato Y., Shima M., Ishii N., Tamaoki T., and Nagataki S. Interaction of interferon-α with interleukin-1β or tumor necrosis factor-α on hepatitis B virus enhancer activity. Biochem. Biophys. Res. Commun. 183 (1992) 904-909
15. Hannoun C., Horal P., Krogsgaard K., and Lindh M. Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B. J. Med. Virol. 66 (2002) 171-178
16. Kurosaki M., Enomoto N., Asahina Y., Sakuma I., Ikeda T., Tozuka S., Izumi N., Marumo F., and Sato C. Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B. J. Med. Virol. 49 (1996) 115-123
17. Li J., Buckwold V.E., Hon M.W., and Ou J.H. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J. Virol. 73 (1999) 1239-1244
18. Lindh M., Hannoun C., Dhillon A.P., Norkrans G., and Horal P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J. Infect. Dis. 179 (1999) 775-782
19. Marcellin P., Chang T.T., Lim S.G., Tong M.J., Sievert W., Shiffman M.L., Jeffers L., Goodman Z., Wulfsohn M.S., Xiong S., Fry J., Brosgart C.L., and Adefovir Dipivoxil 437 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N. Engl. J. Med. 348 (2003) 808-816
20. Moriyama K. Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter. J. Gen. Virol. 78 (1997) 1479-1486
21. Nishizono A., Hiraga M., Kohno K., Sonoda Y.T., Terao H., Fujioka T., Nasu M., and Mifune K. Mutations in the core promoter/enhancer II regions of naturally occurring hepatitis B virus variants and analysis of the effects on transcription activities. Intervirology 38 (1995) 290-294
22. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa Y., and Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 68 (1994) 8102-8110
23. Rang A., Gunther S., and Will H. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. J. Hepatol. 31 (1999) 791-799
24. Summers J., and Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29 (1982) 403-415
25. Wen Y.M., He L.F., and Lou H.Z. The expression of HBV DNA in HepG2 cells. Natl. Med. J. China 69 (1986) 260-263
26. Will H., Reiser W., Weimer T., Pfaff E., Buscher M., Sprengel R., Cattaneo R., and Schaller H. Replication strategy of human hepatitis B virus. J. Virol. 61 (1987) 904-911
27. Yu X.M., and Mertz J.E. Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. J. Virol. 70 (1996) 8719-8726
28. Yuh C.H., Chang Y.L., and Ting L.P. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J. Virol. 66 (1992) 4073-4084